The Atrial Fibrillation Registry (The FLOW‐AF Registry): Insights From the United Arab Emirates—Patient Characteristics, Treatment, and One‐Year Outcomes
The FLOW-AF Registry provides valuable insights into NVAF management in the UAE, demonstrating a distinct patient profile and a preference for NOACs. The NVAF cohort in the UAE was characterized by a younger demographic with lower risk scores and lower rate of clinical events relative to global counterparts. The findings underscore the evolving approach to AF management in the UAE, suggestive of a shift towards NOAC use but also highlights the need for ongoing research to fully understand long-term outcomes and validate current treatment paradigms in the UAE.
Authors
- Amrish Agrawal (ORCID: https://orcid.org/0000-0003-1863-2455)
- Omneya Hassanain (ORCID: https://orcid.org/0000-0001-5912-6773)
- Ghazi Radaideh
- Haytham Mohamed Ahmed (ORCID: https://orcid.org/0000-0002-2883-3317)
- Wael Almahmeed (ORCID: https://orcid.org/0000-0003-0312-9910)
- Natasha Khalife
- Mohamed Magdy
- Moutaz El Kadri (ORCID: https://orcid.org/0000-0003-3761-5546)
- Khalid AlMuti
- Mohamed Fathy Soliman Gamaleldin
- Nooshin Bazargani
Institutions
- Oasis Hospital (AE)
- Rashid Hospital (AE)
- Shaikh Khalifa Medical City (AE)
- Dubai Hospital (AE)
Publication Details
- Journal
- Journal of Cardiovascular Electrophysiology
- Published
- 2025-02-10
- DOI
- https://doi.org/10.1111/jce.16598
- Citations
- 1
- Primary Topic
- Atrial Fibrillation Management and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 1.39
Funders
- Pfizer